1. Home
  2. BNC vs TOI Comparison

BNC vs TOI Comparison

Compare BNC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

HOLD

Current Price

$2.63

Market Cap

287.3M

Sector

Industrials

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.54

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNC
TOI
Founded
N/A
2007
Country
United States
United States
Employees
N/A
641
Industry
Industrial Machinery/Components
Medical/Nursing Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.3M
304.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNC
TOI
Price
$2.63
$3.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
194.7K
1.5M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.15
Revenue Next Year
N/A
$25.77
P/E Ratio
$0.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.39
$2.01
52 Week High
$31.62
$4.88

Technical Indicators

Market Signals
Indicator
BNC
TOI
Relative Strength Index (RSI) 36.77 65.24
Support Level $2.39 $3.35
Resistance Level $3.05 $3.74
Average True Range (ATR) 0.21 0.20
MACD 0.05 0.03
Stochastic Oscillator 43.19 94.71

Price Performance

Historical Comparison
BNC
TOI

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: